CRIS Current Research Information System

SIRICO, MARIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.120
NA - Nord America 629
EU - Europa 366
Continente sconosciuto - Info sul continente non disponibili 74
SA - Sud America 31
AF - Africa 26
OC - Oceania 2
Totale 2.248
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 593
CN - Cina 301
SG - Singapore 297
VN - Vietnam 192
IT - Italia 176
BD - Bangladesh 103
HK - Hong Kong 82
KR - Corea 60
FR - Francia 40
NL - Olanda 40
IN - India 28
DE - Germania 27
BR - Brasile 21
JP - Giappone 19
FI - Finlandia 18
CA - Canada 14
CI - Costa d'Avorio 13
MX - Messico 12
GB - Regno Unito 11
SE - Svezia 10
AT - Austria 8
ID - Indonesia 8
PL - Polonia 6
SC - Seychelles 6
CH - Svizzera 5
AR - Argentina 4
ES - Italia 4
PH - Filippine 4
RU - Federazione Russa 4
TH - Thailandia 4
BE - Belgio 3
IE - Irlanda 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
CO - Colombia 2
EG - Egitto 2
GH - Ghana 2
GR - Grecia 2
GT - Guatemala 2
IQ - Iraq 2
JM - Giamaica 2
JO - Giordania 2
MY - Malesia 2
SA - Arabia Saudita 2
TW - Taiwan 2
UA - Ucraina 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CG - Congo 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
HN - Honduras 1
IL - Israele 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
RO - Romania 1
SV - El Salvador 1
TR - Turchia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 2.175
Salva come PNG Salva come JPEG
Città #
Singapore 185
Hefei 152
San Jose 137
Hong Kong 73
Council Bluffs 58
Seoul 56
Dallas 54
Hanoi 49
Ashburn 43
Ho Chi Minh City 42
Los Angeles 33
Santa Clara 27
New York 26
Lauterbourg 25
Amsterdam 24
Milan 22
Beijing 19
Bologna 19
Bengaluru 16
Tokyo 16
Buffalo 15
Abidjan 13
Rome 13
Helsinki 10
Boardman 9
Haiphong 9
Lappeenranta 8
São Paulo 8
Mexico City 7
Chicago 6
Da Nang 6
Falkenstein 6
Jakarta 6
Casalecchio di Reno 5
Frankfurt am Main 5
Guangzhou 5
Modena 5
Munich 5
Nuremberg 4
Quincy 4
Ravenna 4
Shanghai 4
Zurich 4
Bắc Giang 3
Castel Maggiore 3
Des Moines 3
Dublin 3
Huizhou 3
Monzuno 3
New Delhi 3
Ninh Bình 3
North Charleston 3
Orem 3
Philadelphia 3
Phoenix 3
Reggio Emilia 3
Thái Nguyên 3
Venice 3
Vienna 3
Warsaw 3
Acalanes Ridge 2
Accra 2
Alghero 2
Amman 2
Antioch 2
Bagnacavallo 2
Bozeman 2
Bắc Ninh 2
Camden 2
City of London 2
Cleveland 2
DeKalb 2
Düsseldorf 2
Genoa 2
Hải Dương 2
Inglewood 2
Kingston 2
London 2
Lowell 2
Montreal 2
Mumbai 2
Osaka 2
Ottawa 2
Palermo 2
Pasadena 2
Perugia 2
Qingdao 2
Quận Bình Thạnh 2
Roccalumera 2
San Antonio 2
San Francisco 2
Spinea 2
Tainan 2
Tashkent 2
Tirana 2
Tongling 2
Toronto 2
Trani 2
Trevi 2
Turin 2
Totale 1.368
Salva come PNG Salva come JPEG
Nome #
Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer 186
Oligometastatic breast cancer and metastasis-directed treatment: an aggressive multimodal approach to reach the cure 156
Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives 149
Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 study 133
Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: biomarkers and beyond 128
Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment 128
Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology 122
Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast Cancer 115
Current State and Future Challenges for PI3K Inhibitors in Cancer Therapy 103
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors 93
Local treatment for oligoprogressive metastatic sites of breast cancer: efficacy, toxicities and future perspectives 88
Next-generation sequencing-based evaluation of the actionable landscape of genomic alterations in solid tumors: the "MOZART" prospective observational study 83
An update on antibody–drug conjugates in urothelial carcinoma: state of the art strategies and what comes next 80
Pharmacological Prevention in Breast Cancer: Current Evidence, Challenges, and Future Directions 65
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study 62
ROLE OF HPV VACCINATION AFTER CARCINOMA IN SITU OF CERVIX UTERI (CIN) IN REAL-WORLD PATIENTS 60
Implications of hormonal carcinogenesis for transgender and gender-diverse people undergoing gender-affirming hormone therapy: an up-to-date review 60
Hormonal Therapy For Endometriosis And The Risk Of Endometriosis-Associated Gynecologic Cancers: A Propensity Score-Adjusted Real-World Data Study 52
Advances in anti-BRAF therapies for lung cancer 49
Hallmarks of Appetite: A Comprehensive Review of Hunger, Appetite, Satiation, and Satiety 42
Early Changes of the Standardized Uptake Values (SUVmax) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer 41
Canakinumab as treatment for COVID-19-related pneumonia: A prospective case-control study 38
ΔKi67 proliferation index as independent predictive and prognostic factor of outcome in luminal breast cancer: data from neoadjuvant letrozole-based treatment 37
Corrigendum to “Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives” [Crit. Rev. Oncol./Hematol. 181 (2023) 103900] (Critical Reviews in Oncology / Hematology (2023) 181, (S1040842822003249), (10.1016/j.critrevonc.2022.103900)) 35
Cancer management during the COVID-19 world pandemic 34
Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study 30
Corrigendum to “Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: Biomarkers and beyond” [Crit. Rev. Oncol./Hematol. 200C (2024) 104404](S1040842824001471)(10.1016/j.critrevonc.2024.104404) 23
Efficacy of extended aromatase inhibitors for hormone-receptor-positive breast cancer: A literature-based meta-analysis of randomized trials 22
Artificial intelligence for predicting pathological complete response to neoadjuvant therapy in triple-negative breast cancer: A systematic review and meta-analysis 17
Bevacizumab and Platinum Choice in Pembrolizumab-Treated Advanced Cervical Cancer 17
Totale 2.248
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.291
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.291
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202435 0 0 0 0 0 0 6 1 12 12 2 2
2024/2025285 10 23 19 25 20 18 9 19 1 17 38 86
2025/20261.765 68 127 237 147 121 60 242 94 276 124 203 66
2026/2027163 59 104 0 0 0 0 0 0 0 0 0 0
Totale 2.248